Asia-Pacific Journal of Pharmacotherapy & Toxicology

About AUO

Scope and criteria for publication

Annals of Urologic Oncology (AUO) (print ISSN: 2617-7765, online ISSN: 2617-7773) is an open access, international, peer-reviewed journal, published by Asian Medical Press Limited in Hong Kong, China. It is published biannually and is openly distributed worldwide. AUO publishes the results of novel research in the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human urologic oncology with the overall goal of improving the clinical care of patients with urologic tumor. Special topics are arranged in each published issue in the journal including three main subjects: bladder, prostate and kidney cancer.

The journal focuses on publishing some high-quality reviews on physiopathology, diagnosis and treatment of urologic oncology. Peer-reviewed manuscript types include reviews, original reports, and brief letters. All manuscripts submitted to the journal will be rapidly sent to be reviewed by our peer reviewers to improve its quality. Manuscript with high quality will be accepted and published online.

AUO is indexed and covered by Google Scholar, ResearchGate and DOAJ now.We will timely apply index of electronic database including PubMed, Medline, and Web of Science for the journal.

Turnaround times for manuscripts after submission

  • First editorial decision - 7 days
  • Peer review - 2 weeks
  • Revision time - 1-4 weeks
  • Ahead of Print - within 1 month of being accepted
  • Formal publication - within 1-12 month of being accepted

Submit your manuscript

To know more about submission to AUO, please read our author instructions to prepare a manuscript.